Literature DB >> 8120407

Production of interleukin-1 receptor antagonist, inflammatory chemotactic proteins, and prostaglandin E by rheumatoid and osteoarthritic synoviocytes--regulation by IFN-gamma and IL-4.

M Seitz1, P Loetscher, B Dewald, H Towbin, M Ceska, M Baggiolini.   

Abstract

This study analyzes the effects of the T cell cytokines IL-4 and IFN-gamma on the spontaneous and stimulated production of IL-8, MCP-1, IL-1 receptor antagonist (IL-1ra), and PGE by synoviocytes from rheumatoid arthritis (RA) and osteoarthritis (OA) patients. Cells from both sources constitutively released IL-8 and MCP-1, but no IL-1ra or PGE. Stimulation with IL-1 beta or TNF-alpha massively increased chemokine production and induced the generation of PGE and low amounts of IL-1ra. The constitutive or cytokine-stimulated release of IL-8 was inhibited by IFN-gamma, but not by IL-4. The constitutive or IL-1 beta-stimulated release of MCP-1, by contrast, was markedly enhanced by IL-4 and IFN-gamma. Both cytokines, however, had only borderline effects on the release stimulated by TNF-alpha. The yield of IL-1ra was strongly enhanced by IFN-gamma in all cases, whereas the effect of IL-4 was pronounced only in IL-1 beta-stimulated OA synoviocytes. IL-4, on the other hand, markedly decreased the release of PGE, which was less susceptible to IFN-gamma. The observed effects on chemokines, IL-1ra expression, and PGE release by synoviocytes suggest that IFN-gamma and IL-4 are important regulatory elements in the inflamed synovium and may exert anti-inflammatory effects.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8120407

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA).

Authors:  M M Luchetti; G Piccinini; A Mantovani; G Peri; C Matteucci; G Pomponio; M Fratini; P Fraticelli; P Sambo; C Di Loreto; A Doni; M Introna; A Gabrielli
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

2.  Identification of a cytokine-induced repressor of interleukin-1 stimulated expression of stromelysin 1 (MMP-3).

Authors:  R C Borghaei; C Sullivan; E Mochan
Journal:  J Biol Chem       Date:  1999-01-22       Impact factor: 5.157

Review 3.  The Multifunctional Role of the Chemokine System in Arthritogenic Processes.

Authors:  Giovanni Bernardini; Giorgia Benigni; Rossana Scrivo; Guido Valesini; Angela Santoni
Journal:  Curr Rheumatol Rep       Date:  2017-03       Impact factor: 4.592

4.  Regulation of early complement components C3 and C4 in the synovium.

Authors:  T Collins; J A Winkelstein; K E Sullivan
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

Review 5.  Chemokines and tissue injury.

Authors:  M B Furie; G J Randolph
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

6.  Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4.

Authors:  F Q Cunha; S Poole; B B Lorenzetti; F H Veiga; S H Ferreira
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

Review 7.  Chemokines in joint disease: the key to inflammation?

Authors:  J J Haringman; J Ludikhuize; P P Tak
Journal:  Ann Rheum Dis       Date:  2004-04-13       Impact factor: 19.103

8.  Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis.

Authors:  G D Anderson; S D Hauser; K L McGarity; M E Bremer; P C Isakson; S A Gregory
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

9.  Interleukin-4 suppression of interleukin-1-induced transcription of collagenase (MMP-1) and stromelysin 1 (MMP-3) in human synovial fibroblasts.

Authors:  R C Borghaei; P L Rawlings; E Mochan
Journal:  Arthritis Rheum       Date:  1998-08

10.  Transient expression of the diseased phenotype of osteoarthritic chondrocytes in engineered cartilage.

Authors:  Amy M Silverstein; Aaron M Stoker; Gerard A Ateshian; J Chloe Bulinski; James L Cook; Clark T Hung
Journal:  J Orthop Res       Date:  2016-05-29       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.